Daniel Arias
Stock Analyst at Stifel Nicolaus
(3.14)
# 2,486
Out of 4,442 analysts
492
Total ratings
45.3%
Success rate
2.2%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Maintained: Hold | $36 | $37.20 | -3.23% | 19 | Jun 16, 2026 | |
| ALMR Alamar Biosciences | Maintained: Buy | $28 | $22.94 | +22.06% | 2 | Jun 9, 2026 | |
| TEM Tempus AI | Maintained: Hold | $60 | $48.61 | +23.43% | 11 | Jun 1, 2026 | |
| A Agilent Technologies | Maintained: Buy | $170 | $126.67 | +34.21% | 26 | May 28, 2026 | |
| GH Guardant Health | Maintained: Buy | $130 | $130.83 | -0.63% | 17 | May 28, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $600 | $469.35 | +27.84% | 31 | May 21, 2026 | |
| MTD Mettler-Toledo International | Rated: Buy | $1,600 → $1,400 | $1,156.64 | +21.04% | 29 | May 18, 2026 | |
| WAT Waters | Maintained: Hold | $380 | $357.20 | +6.38% | 28 | May 18, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 | $1.69 | +373.37% | 6 | May 14, 2026 | |
| MXCT MaxCyte | Maintained: Buy | $4 | $1.18 | +240.43% | 15 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $5.37 | +11.73% | 24 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $55.11 | -18.35% | 23 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $50 | $56.26 | -11.13% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $10 | $8.73 | +14.55% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 | $104.28 | +39.05% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 → $100 | $99.90 | +0.10% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $207 | $126.37 | +63.80% | 31 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 | $164.93 | -6.02% | 47 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $8 | $9.43 | -15.16% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 | $178.97 | +45.28% | 26 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $25 | $31.87 | -21.56% | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.39 | +109.21% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.41 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $1.11 | n/a | 13 | Mar 1, 2024 |
Qiagen
Jun 16, 2026
Maintained: Hold
Price Target: $36
Current: $37.20
Upside: -3.23%
Alamar Biosciences
Jun 9, 2026
Maintained: Buy
Price Target: $28
Current: $22.94
Upside: +22.06%
Tempus AI
Jun 1, 2026
Maintained: Hold
Price Target: $60
Current: $48.61
Upside: +23.43%
Agilent Technologies
May 28, 2026
Maintained: Buy
Price Target: $170
Current: $126.67
Upside: +34.21%
Guardant Health
May 28, 2026
Maintained: Buy
Price Target: $130
Current: $130.83
Upside: -0.63%
Thermo Fisher Scientific
May 21, 2026
Maintained: Buy
Price Target: $600
Current: $469.35
Upside: +27.84%
Mettler-Toledo International
May 18, 2026
Rated: Buy
Price Target: $1,600 → $1,400
Current: $1,156.64
Upside: +21.04%
Waters
May 18, 2026
Maintained: Hold
Price Target: $380
Current: $357.20
Upside: +6.38%
Rapid Micro Biosystems
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.69
Upside: +373.37%
MaxCyte
May 13, 2026
Maintained: Buy
Price Target: $4
Current: $1.18
Upside: +240.43%
May 11, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $5.37
Upside: +11.73%
May 8, 2026
Rated: Hold
Price Target: $40 → $45
Current: $55.11
Upside: -18.35%
May 7, 2026
Maintained: Hold
Price Target: $65 → $50
Current: $56.26
Upside: -11.13%
May 7, 2026
Rated: Buy
Price Target: $8 → $10
Current: $8.73
Upside: +14.55%
May 7, 2026
Rated: Buy
Price Target: $145
Current: $104.28
Upside: +39.05%
May 6, 2026
Rated: Hold
Price Target: $110 → $100
Current: $99.90
Upside: +0.10%
May 6, 2026
Maintained: Buy
Price Target: $207
Current: $126.37
Upside: +63.80%
May 1, 2026
Maintained: Buy
Price Target: $155
Current: $164.93
Upside: -6.02%
Apr 30, 2026
Maintained: Hold
Price Target: $10 → $8
Current: $9.43
Upside: -15.16%
Apr 22, 2026
Maintained: Buy
Price Target: $260
Current: $178.97
Upside: +45.28%
Mar 2, 2026
Maintained: Buy
Price Target: $20 → $25
Current: $31.87
Upside: -21.56%
Nov 10, 2025
Maintained: Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $7.41
Upside: n/a
Mar 1, 2024
Maintained: Buy
Price Target: $5
Current: $1.11
Upside: n/a